(S (NP (DT This) (NN work)) (VP (VBZ aims) (S (VP (VP (TO to) (VP (VB study) (NP (NP (DT the) (NN generalizability)) (PP (IN of) (NP (NP (DT a) (JJ pre-developed) (JJ deep) (NN learning) (PRN (-LRB- -LRB-) (NNP DL) (-RRB- -RRB-)) (VBP dose) (NN prediction) (NN model)) (PP (IN for) (NP (NP (JJ volumetric) (VBN modulated) (JJ arc) (NN therapy)) (PRN (-LRB- -LRB-) (NP (NNP VMAT)) (-RRB- -RRB-)) (PP (IN for) (NP (NN prostate) (NN cancer)))))))))) (CC and) (VP (TO to) (VP (VB adapt) (NP (DT the) (NN model)) (PP (TO to) (NP (NP (CD three) (JJ different) (JJ internal) (NN treatment) (NN planning) (NNS styles)) (CC and) (NP (CD one) (JJ external) (NN institution) (NN planning) (NN style))))))))) (. .))
(S (NP (PRP We)) (VP (VBD built) (NP (DT the) (NN source) (NN model)) (PP (IN with) (NP (NP (VBG planning) (NNS data)) (PP (IN from) (NP (NP (CD 108) (NNS patients)) (VP (ADVP (RB previously)) (VBN treated) (PP (IN with) (NP (NNP VMAT))) (PP (IN for) (NP (NN prostate) (NN cancer))))))))) (. .))
(S (PP (IN For) (NP (DT the) (NN transfer) (NN learning))) (, ,) (NP (PRP we)) (VP (VBD selected) (NP (NP (JJ patient) (NNS cases)) (VP (VBN planned) (PP (IN with) (NP (NP (NP (CD three) (JJ different) (NNS styles)) (PP (IN from) (NP (DT the) (JJ same) (NN institution)))) (CC and) (NP (NP (CD one) (NN style)) (PP (IN from) (NP (DT a) (JJ different) (NN institution)))))))) (S (VP (TO to) (VP (VB adapt) (NP (DT the) (NN source) (NN model)) (PP (TO to) (NP (CD four) (NN target) (NNS models))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBN compared) (NP (NP (DT the) (JJ dose) (NNS distributions)) (VP (VBN predicted) (PP (IN by) (NP (NP (DT the) (NN source) (NN model)) (CC and) (NP (DT the) (NN target) (NNS models)))))) (PP (IN with) (NP (DT the) (JJ clinical) (NN dose) (NNS predictions)))) (CC and) (VP (VBD quantified) (NP (NP (DT the) (NN improvement)) (PP (IN in) (NP (NP (DT the) (NN prediction) (NN quality)) (PP (IN for) (NP (DT the) (NN target) (NNS models))))) (PP (IN over) (NP (DT the) (NN source) (NN model)))) (S (VP (VBG using) (NP (NP (NP (DT the) (NNP Dice) (NN similarity) (NNS coefficients)) (PRN (-LRB- -LRB-) (NP (NNP DSC)) (-RRB- -RRB-)) (PP (IN of) (NP (QP (CD 10) (NN %) (TO to) (CD 100) (NN %)) (JJ isodose) (NNS volumes)))) (CC and) (NP (NP (DT the) (NN dose-volume-histogram) (PRN (-LRB- -LRB-) (NNP DVH) (-RRB- -RRB-)) (NNS parameters)) (PP (IN of) (NP (NP (DT the) (NN planning) (NN target) (NN volume)) (CC and) (NP (DT the) (JJ organs-at-risk)))))))))) (. .))
(S (NP (DT The) (NN source) (NN model)) (VP (VP (ADVP (RB accurately)) (VBZ predicts) (NP (JJ dose) (NNS distributions)) (PP (IN for) (NP (NP (NNS plans)) (VP (VBN generated) (PP (IN in) (NP (DT the) (JJ same) (NN source) (NN style))))))) (CC but) (VP (VBZ performs) (ADVP (RB sub-optimally)) (PP (IN for) (NP (DT the) (CD three) (ADJP (JJ internal) (CC and) (ADJP (CD one) (JJ external))) (NN target) (NNS styles))) (, ,) (PP (IN with) (S (NP (DT the) (NN mean) (NNP DSC)) (VP (VBG ranging) (PP (IN between) (NP (JJ 0.81-0.94) (CC and) (JJ 0.82-0.91))) (PP (IN for) (NP (NP (DT the) (ADJP (ADJP (JJ internal)) (CC and) (NP (DT the) (JJ external))) (NNS styles)) (, ,) (ADVP (RB respectively))))))))) (. .))
(S (PP (IN With) (NP (NN transfer) (NN learning))) (, ,) (NP (DT the) (NN target) (NN model) (NNS predictions)) (VP (VBD improved) (NP (DT the) (JJ mean) (NNP DSC)) (PP (TO to) (NP (CD 0.88-0.95) (CC and) (CD 0.92-0.96))) (PP (IN for) (NP (NP (DT the) (ADJP (JJ internal) (CC and) (NP (DT the) (JJ external))) (NNS styles)) (, ,) (ADVP (RB respectively))))) (. .))
(S (NP (NNP Target) (NN model) (NNS predictions)) (VP (ADVP (RB significantly)) (VBD improved) (NP (NP (DT the) (NN accuracy)) (PP (IN of) (NP (DT the) (NNP DVH) (NN parameter) (NNS predictions)))) (PP (TO to) (ADVP (IN within) (CD 1.6) (NN %)))) (. .))
(S (NP (PRP We)) (VP (VBD demonstrated) (NP (NP (NP (NN model) (NN generalizability)) (PP (IN for) (NP (JJ DL-based) (JJ dose) (NN prediction)))) (CC and) (NP (NP (DT the) (NN feasibility)) (PP (IN of) (S (VP (VBG using) (NP (NN transfer) (VBG learning)) (S (VP (TO to) (VP (VB solve) (NP (DT this) (NN problem))))))))))) (. .))
(S (PP (IN With) (NP (NP (JJ 14-29) (NNS cases)) (PP (IN per) (NP (NN style))))) (, ,) (NP (PRP we)) (VP (ADVP (RB successfully)) (VBD adapted) (NP (DT the) (NN source) (NN model)) (PP (IN into) (NP (JJ several) (JJ different) (NN practice) (NNS styles)))) (. .))
(S (NP (DT This)) (VP (VBZ indicates) (NP (NP (DT a) (JJ realistic) (NN way)) (PP (TO to) (NP (NP (JJ widespread) (JJ clinical) (NN implementation)) (PP (IN of) (NP (JJ DL-based) (JJ dose) (NN prediction))))))) (. .))
